Sleep and Alzheimer: The Link.
Archana Gaur1, Ariyanachi Kaliappan2, Yuvaraj Balan3
1Department of Physiology, All India Institute of Medical Science, Bibinagar, Hyderabad, Telangana, India.
Maedica
|June 23, 2022
Summary
Sleep deprivation and insomnia are linked to Alzheimer's disease progression and cognitive decline. Managing sleep disturbances may help prevent dementia symptoms and cognitive impairment.
Area of Science:
- Neuroscience
- Gerontology
- Sleep Medicine
Background:
- Alzheimer's disease (AD) is a leading cause of dementia, characterized by cognitive and non-cognitive impairments.
- Emerging research links sleep deprivation and insomnia to the underlying pathophysiology and progression of AD.
- Understanding this connection is crucial for developing effective interventions.
Discussion:
- Sleep disturbances significantly impact AD pathophysiology, including neuroinflammation and oxidative stress.
- Lack of sleep exacerbates tau protein generation and amyloid-beta (Aβ) deposition, key hallmarks of AD.
- These mechanisms highlight how poor sleep contributes to cognitive decline in AD patients.
Key Insights:
- Sleep deprivation is a critical factor influencing Alzheimer's disease development and symptom severity.
- Neuroinflammation, oxidative stress, and sleep disturbances are central to AD pathology.
- Targeting sleep issues presents a potential strategy for mitigating AD progression.
Outlook:
- Further research into sleep's role in AD can reveal novel therapeutic targets.
- Developing interventions to manage sleep disturbances may offer a preventative approach to cognitive decline.
- Integrating sleep management into AD care could improve patient outcomes and quality of life.
More Related Videos
Related Concept Videos
01:26Alzheimer's Disease: Overview
663
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
663
01:13Insufficient Sleep and Sleep Deprivation
209
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
209
01:11Understanding Sleep
487
Sleep, an essential biological state, involves significant reductions in physical activity, sensory awareness, and interaction with the environment. This complex physiological process is primarily regulated by specific brain regions, notably the hypothalamus and pons, which govern the sleep-wake cycle or circadian rhythm.
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
487
01:22Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
01:17Sleepwalking and Sleep Talking
302
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
302
01:24Substance Use Disorders Affecting Sleep
216
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
216